Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

During the Trading Day
143.78 -3.39 / -2.30%
As of 4:14pm ET
Day’s Change
During After-Hours   Switch to standard view »
143.80 +0.0173 / +0.01%
 
Volume: 22.7K

Today’s Trading

Previous close147.17
Today’s open145.00
Day’s range141.92 - 147.76
Volume1,624,488
Average volume (3 months)1,310,891
Market cap$23.5B
Dividend yield--
Data as of 4:14pm ET, 08/04/2015

Growth & Valuation

Earnings growth (last year)+28.13%
Earnings growth (this year)-133.05%
Earnings growth (next 5 years)+40.30%
Revenue growth (last year)+36.76%
P/E ratioNM
Price/Sales17.64
Price/Book14.27

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc+0.37+0.76%
MYLMylan NV-0.53-0.96%
PRGOPerrigo Company PLC-1.86-0.97%
INCYIncyte Corp+5.76+5.54%
Data as of 4:01pm ET, 08/04/2015

Financials

Last reporting dateAugust 4, 2015
EPS forecast (this quarter)-$0.55
Annual revenue (last year)$750.0M
Annual profit (last year)-$134.0M
Net profit margin-17.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Daniel K. Spiegelman
Corporate headquarters
San Rafael, California

Forecasts